Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Kedudukan dalam Saham #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Harga Saham
$152.40
Modal Pasaran
$376.40B
Perubahan (1 hari)
12.48%
Perubahan (1 tahun)
79.44%
Negara
US
Perdagangan Merck & Co., Inc. (MRK)

Kategori

Hasil untuk Merck & Co., Inc. (MRK)
Hasil pada Jun 2026 TTM: $66.40B
Menurut laporan kewangan terkini daripada Merck & Co., Inc., hasil semasa syarikat (TTM) ialah $66.40B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $64.17B peningkatan berbanding hasil pada tahun 2023 iaitu $60.12B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Merck & Co., Inc. dari 2000 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $66.40B 2.14%
2025 $65.01B 1.31%
2024 $64.17B 6.74%
2023 $60.12B 1.40%
2022 $59.28B 21.72%
2021 $48.70B 17.31%
2020 $41.52B 6.13%
2019 $39.12B -7.50%
2018 $42.29B 5.41%
2017 $40.12B 0.79%
2016 $39.81B 0.78%
2015 $39.50B -6.48%
2014 $42.24B -4.08%
2013 $44.03B -6.84%
2012 $47.27B -1.62%
2011 $48.05B 4.48%
2010 $45.99B 67.66%
2009 $27.43B 15.00%
2008 $23.85B -1.44%
2007 $24.20B 6.90%
2006 $22.64B 2.84%
2005 $22.01B -4.18%
2004 $22.97B 2.17%
2003 $22.49B 4.85%
2002 $21.45B 1.16%
2001 $21.20B -47.48%
2000 $40.36B 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$79.67B 19.98%
US
$97.93B 47.48%
US
$64.39B -3.03%
US
$77.52B 16.74%
CH
$56.26B -15.27%
CH